ProBase Pharma Overview

  • Founded
  • 2012

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

ProBase Pharma General Information


Provider of laboratory contract services intended to offer molecular-based rapid testing services. The company's services offers molecular biological testing methods on pharmaceutical raw materials, process intermediates, and finished products, enabling clients to identify bacteria using molecular methods such as PCR, DNA sequencing, and mass spectrometry.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Parent Company
Primary Office
  • Sylviusweg 74
  • 2333 BE Leiden
  • Netherlands
+31 071 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProBase Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 13-Jan-2016 Completed Generating Revenue
2. Early Stage VC Completed Generating Revenue
1. Joint Venture 01-Jan-2012 Completed Generating Revenue
To view ProBase Pharma’s complete valuation and funding history, request access »

ProBase Pharma Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Jonghoud International Family Office Minority 000 0000 000000 0
Sinensis Life Sciences Corporation Majority 000 0000 000000 0
To view ProBase Pharma’s complete investors history, request access »